E-NEWS FROM THE NATIONAL
VACCINE INFORMATION CENTER
Vienna, Virginia http://www.909shot.com
* * * * * * * * * * * * * *
* * * * * * * * *
UNITED WAY/COMBINED FEDERAL CAMPAIGN
#9119
* * * * * * * * * * * * * *
* * * * * * * * *
"Protecting the health
and informed consent rights of children since 1982."
==========================================================================================
NVIC Note: The Frist bill
did not make it to the mark-up. Congress is
currently in recess but we
expect this bill to come back this year. Thank
you for all the faxes,
e-mails and phone calls. Here is an article that
explains why the drug
companies are scrambling to stop vaccine lawsuits.
From LexisNexis
Vaccine Act Time-Bar Defense
Remanded To Oregon State Court
Matt Nestlen, et al. v.
Aventis Pasteur Inc., et al.
PORTLAND, Ore. - Aug. 8,
2002
Whether the National Vaccine
Injury Compensation Act's 36-month statute of
limitations bars claims from
being raised in state court is a question to be
decided in state courts, a
federal judge ruled July 30 in remanding a
thimerosal/autism claim.
(Matt Nestlen, et al. v. Aventis Pasteur Inc., et
al., No. 02-457-BR, D. Ore.)
Matt and Kelly Nestlen
earlier this year sued Aventis Pasteur Inc.,
SmithKline Beecham Corp.
(now GlaxoSmithKline plc), Eli Lilly and Co.,
Virginia Feldman, M.D., and
Kaiser Foundation Health Plan of the Northwest
in Oregon state court,
asserting state law claims for strict products
liability, negligence and
medical malpractice. They claim that thimerosal in
vaccines made by the
manufacturing defendants and administered by the
physician defendants caused
autism in their son, Daniel Nestlen.
GlaxoSmithKline (GSK)
removed the case to the U.S. District Court for the
District of Oregon on the
grounds of federal jurisdiction under the Vaccine
Act and diversity of
citizenship. The four other defendants consented to
removal.
GSK argued that Feldman, an
Oregon citizen, was fraudulently joined to
defeat diversity. It also
argued that the Nestlens' vaccine-related injuries
are barred in state or
federal court because they should have been filed
with the U.S. Court of
Federal Claims' "Vaccine Court" within the federal
law's 36-month time limit.
U.S. Judge Anna J. Brown of
the District of Oregon noted that in two other
thimerosal cases - King v.
Aventis Pasteur (CV-01-1305-BR; See July 2002,
Page 8) and Mead v. Aventis
Pasteur (CV-01-1402-BR; See July 2002, Page 3) -
the District Court ruled
that it could not reach the merits of the Vaccine
Act defense.
"[T]he court is
generally limited to a plaintiff's pleadings when deciding
whether a cause of action is
stated for purposed of fraudulent joinder and
may not consider a
defendant's defenses to the plaintiff's claims," Judge
Brown wrote, explaining Mead
and King. "This Court specifically held the
reach of the Vaccine Act's
bar to suit arose outside of the plaintiffs'
claims and required the
Court to consider instead the defendants'
substantive defenses to
those claims."
=============================================
News@909shot.com is a free
service of the National Vaccine Information
Center and is supported
through membership donations. Learn
more about vaccines, diseases and how to protect your informed
consent rights http://www.909shot.com
Become a member and support
NVIC's work
https://www.909shot.com/order.htm
To sign up for a free e-mail
subscription http://www.909shot.com/emaillist.htm
To unsubscribe from this
list, send an email to news-request@909shot.com and type
UNSUBSCRIBE in the body of
the email.
NVIC is funded through
individual membership donations and does not receive government funding.
Barbara Loe Fisher, President and Co-founder.
NOTE: This is not an
interactive e-mail list. Please do not respond to messages.
ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.